Ong Khang Chuen

Analysts remain positive on Silverlake Axis – albeit with lower TP – as it awaits big contract wins - THE EDGE SINGAPORE

Broker's Calls

Analysts remain positive on Silverlake Axis – albeit with lower TP – as it awaits big contract wins

Analysts from CGS-CIMB Research and DBS Group Research have kept “buy” on Silverlake Axis, despite lower-than-expected net profit reported for the 3QFY2021 and 9MFY2021.

CGS-CIMB forecasts record 1Q21 for Jiutian Chemical Group on DMF price uptrend - THE EDGE SINGAPORE

Broker's Calls

CGS-CIMB forecasts record 1Q21 for Jiutian Chemical Group on DMF price uptrend

As dimethylformamide (DMF) prices continue on a strong uptrend year-to-date (y-t-d), CGS-CIMB Research analysts Ong Khang Chuen and Kenneth Tan estimate that Jiutian Chemical Group will post a “rec

Continue to 'add' BRC Asia on recovery in construction sector, says CGS-CIMB - THE EDGE SINGAPORE

Broker's Calls

Continue to 'add' BRC Asia on recovery in construction sector, says CGS-CIMB

BRC Asia is on track to double net profit in FY2021 to a record high of $40 million, says CGS-CIMB Research. 

Review of financing framework for DTL a potential catalyst for SBS Transit: CGS-CIMB - THE EDGE SINGAPORE

Broker's Calls

Review of financing framework for DTL a potential catalyst for SBS Transit: CGS-CIMB

CGS-CIMB Research analysts Ong Khang Chuen and Darren Ong are maintaining their ‘add’ call for SBS Transit with an unchanged target price of $3.60 after Minister of Transport Ong Ye Kung said that

'Buy' SBS Transit for road to recovery, favoured over ComfortDelGro: CGS-CIMB - THE EDGE SINGAPORE

Broker's Calls

'Buy' SBS Transit for road to recovery, favoured over ComfortDelGro: CGS-CIMB

SBS Transit is on the road to recovery with further easing of social distancing measures expected soon, says CGS-CIMB analysts Ong Khang Chuen and Darren Ong.

The worst is over for Silverlake Axis, 'buy' despite 1Q21 dip: CGS-CIMB - THE EDGE SINGAPORE

Broker's Calls

The worst is over for Silverlake Axis, 'buy' despite 1Q21 dip: CGS-CIMB

CGS-CIMB is maintaining its ‘add’ call on Silverlake Axis despite seeing its 1QFY2021 results fall short of expectations.

China Sunsine showing 'signs of a recovery': CGS-CIMB - THE EDGE SINGAPORE

Broker's Calls

China Sunsine showing 'signs of a recovery': CGS-CIMB

CGS-CIMB has maintained its “add” call on China Sunsine with a raised target price of 42 cents, up from its previous price of 38 cents due to an expected earnings recovery in 2H20. 

953 Brokers' Digest - THE EDGE SINGAPORE

Broker's Calls

953 Brokers' Digest

BYD
Price target:
UOB Kay Hian “buy” HK$150

‘Buy’ UG Healthcare on the expectation of 50x higher profits: CGS-CIMB - THE EDGE SINGAPORE

Broker's Calls

‘Buy’ UG Healthcare on the expectation of 50x higher profits: CGS-CIMB

CGS-CIMB analyst Ong Khang Chuen says he “remains positive” on UG Healthcare (UGHC) as he believes the global shortage of gloves will persist till at least end 2021, given the “gravity” o

×